| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
| 09/11/2002 | CN1368888A Anti-human mitochondrial a denylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disaese |
| 09/11/2002 | CN1368511A Human protein with cancer inhibiting function and its coding sequence |
| 09/11/2002 | CN1368510A Human protein with suppression to cancer cell growth and its coding sequence |
| 09/11/2002 | CN1368509A Human protein with suppression to cancer cell growth and its coding sequence |
| 09/11/2002 | CN1368508A Human protein with cancer inhibiting function and its coding sequence |
| 09/11/2002 | CN1090676C Expression systems utilizing autolyzing fusion proteins and novel reducing polypeptide |
| 09/10/2002 | US6448476 Plants and plant cells transformation to express an AMPA-N-acetyltransferase |
| 09/10/2002 | US6448380 Complexing |
| 09/10/2002 | US6448379 Inhibitors to il8 receptor binding, including antibodies, that interact with the amino-terminal extracellular domain of the il8 receptor and compete with il8 and other related natural ligands, for receptor-binding. |
| 09/10/2002 | US6448376 Two new proteins which appear to be new members of the e2f gene family, called e2f-5 |
| 09/10/2002 | US6448375 Active and inactive CC-chemokine receptor |
| 09/10/2002 | US6448230 Testis expressed polypeptide |
| 09/10/2002 | US6448223 Antagonists of HMG1 for treating inflammatory conditions |
| 09/10/2002 | US6448222 Antitumor agent; antimetastasis agent |
| 09/10/2002 | US6448078 Inhibiting human vpr interacting protein activity in a cell using a nucletide sequence complementary to a portion of the nucleotide sequence that encodes hvip; anticancer agent |
| 09/10/2002 | US6448077 Chimeric and humanized monoclonal antibodies specific to VEGF receptors |
| 09/10/2002 | US6448075 Method for separating cells using immunorosettes |
| 09/10/2002 | US6448073 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 09/10/2002 | US6448071 Effective competitors to t cell receptors and mhc molecules normally involved in transplant rejection and autoimmune disease |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | US6448043 Enterococcus faecalis EF040 and uses therefor |
| 09/10/2002 | US6448042 These enzymes have been implicated in a variety of disease processes, including tumor cell invasion, tumor angiogenesis and rheumatoid arthritis |
| 09/10/2002 | US6448041 Colon cancer marker |
| 09/10/2002 | US6448037 PgsA |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448035 Disorders mediated by disease states associated with suppressed immune function can be treated by administering a soluble form of the negative signaling lir |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6448021 Cc-chemokine receptor 2 (ccr2) bound by an antibody or functional fragment to block binding of a ligand |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | US6448005 14723 Receptor, a novel G-protein coupled receptor |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447993 Protecting cats from infection by a broad range of fiv strains using a multi-subtype fiv vaccine. multi-subtype fiv vaccines comprising either cell free whole virus or cell lines infected with viruses and vaccinating cats |
| 09/10/2002 | US6447786 Cyclic oligopeptides used as controllers of rna transcription factors in staphylococcus grampositive bacteria; prevention of infections |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447778 Peptide compositions for the treatment of HIV infection |
| 09/10/2002 | US6447776 Monoclonal antibodies against mutant amino acid sequences generated by genetic deletions or point mutations; detection of cancer |
| 09/10/2002 | US6447775 Prevention of endocytosis and metabolism of amyloid precursor proteins by blocking the binding to low density lipoprotein receptors (lrp); antigens |
| 09/10/2002 | US6447773 Member of ATP dependent protease family, clpL |
| 09/10/2002 | CA2163218C New macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions |
| 09/10/2002 | CA2128247C Vaccines based on streptokinase |
| 09/06/2002 | WO2002069232A2 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | WO2002068687A2 Function and application of tob gene in central nervous system of mammal |
| 09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | WO2002068675A2 Product, method and system for identifying collagenase-cleaved type ii collagen |
| 09/06/2002 | WO2002068642A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 09/06/2002 | WO2002068623A2 Genes encoding proteolytic enzymes from aspargilli |
| 09/06/2002 | WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | WO2002068597A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068589A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068585A2 Tip39 polypeptides |
| 09/06/2002 | WO2002068583A2 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | WO2002068476A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | WO2002068475A2 Pharmaceutical composition of f(ab)2 fragments of antibodies and method for the preparation thereof |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068463A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 09/06/2002 | WO2002068461A2 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | WO2002068460A1 Peptide tag for monitoring and purification of proteins |
| 09/06/2002 | WO2002068459A2 Non aggregating fluorescent proteins and methods for using the same |
| 09/06/2002 | WO2002068447A1 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 09/06/2002 | WO2002067985A1 Method for prophylaxis and treatment of porcine reproductive and respiratory syndrome |
| 09/06/2002 | WO2002067862A2 Regulation of the ctl response by macrophage migration inhibitory factor |
| 09/06/2002 | WO2002067859A2 Ascorbic acid analogs for metalloradiopharmaceuticals |
| 09/06/2002 | WO2002067857A2 Modified annexin proteins and methods for preventing thrombosis |
| 09/06/2002 | WO2002067848A2 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE |
| 09/06/2002 | WO2002067760A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 09/06/2002 | WO2002055089A3 Immunoassay technique using multispecific molecules |
| 09/06/2002 | WO2002048182A3 Interferon-alpha induced gene |
| 09/06/2002 | WO2002046415A9 Polynucleotide and polypeptide sequences of putative transporters and ion channells |
| 09/06/2002 | WO2002046216A3 Human sprouty-4 polypeptide |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2002024149A3 Immunogen comprising ligand bound hiv envelpe protein |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2001085785A3 Ph domain-interacting protein |
| 09/06/2002 | WO2001072822B1 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/06/2002 | WO2001064738A3 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/06/2002 | WO2001058915A8 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 09/06/2002 | WO2001048485A9 Selecting library members capable of binding to epitopes |
| 09/06/2002 | WO2001032614A9 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 09/06/2002 | WO2001031021A9 Multiple sclerosis-related superantigen |
| 09/06/2002 | WO2001030851A9 Idiotype vaccines |
| 09/06/2002 | WO2001024681A9 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 09/06/2002 | WO2001018546A9 Screening for inhibitors of 'paired helical filaments' |
| 09/06/2002 | WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 09/06/2002 | WO2001007627A9 Drosophila recombination-associated protein and methods for use |
| 09/06/2002 | CA2846761A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | CA2833423A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2477043A1 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | CA2439294A1 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 09/06/2002 | CA2438884A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2438680A1 Genes encoding proteolytic enzymes from aspargilli |
| 09/06/2002 | CA2438652A1 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | CA2438238A1 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | CA2438205A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2438204A1 Ascorbic acid analogs for metalloradiopharmaceuticals |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437516A1 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | CA2437364A1 Proteins and nucleic acids encoding same |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2434671A1 Methods and compositions for modulating regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |